Question 1

How many shares of CTXR does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 26,335 shares of CTXR (CITIUS PHARMACEUTICALS INC).

Question 2

What is UBS Group AG's CTXR position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's CTXR position is worth $15,933.

Question 3

Is UBS Group AG buying or selling CTXR?

Accepted Answer

In 2026-Q2, UBS Group AG decreased their CTXR position (-52.1% change in shares).

Question 4

When did UBS Group AG first buy CTXR?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CTXR in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	26,335	-52.1%	$15,933	0.0%	$0.61	0
2026-Q1	Decreased	55,025	-28.0%	$49,522	0.0%	$0.74	0
2025-Q4	Increased	76,436	+195.0%	$59,391	0.0%	$0.78	23
2025-Q3	Decreased	25,913	-86.6%	$32,132	0.0%	$1.18	0
2025-Q2	Increased	192,927	+187.0%	$306,755	0.0%	$1.53	38
2025-Q1	Increased	67,215	+143.8%	$100,151	0.0%	$1.55	24
2024-Q4	New	27,567	-	$110,268	0.0%	$3.91	33

CTXR7 quarters

CTXR
7 quarters